Amarin | Passività Correnti



Current Liabilities Cambiamento Data
AbbVie USD 38.75B 4.31B 2024-12
Alnylam Pharmaceuticals USD 1.19B 34.39M 2024-12
Amarin USD 201.55M 28.99M 2024-09
AstraZeneca USD 29.13B 1.26B 2025-03
DBV Technologies USD 30.91M 3.53M 2024-09
GlaxoSmithKline GBP 20.83B 866M 2025-03
Halozyme Therapeutics USD 139.1M 30.28M 2024-12
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
Neurocrine Biosciences USD 507.7M 78M 2024-12
Novartis USD 28.69B 560M 2024-12



Amarin Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.